BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
5-Heptadecylresorcinol, a Biomarker for Whole Grain Rye Consumption, Ameliorates Cognitive Impairments and Neuroinflammation in APP/PS1 Transgenic Mice. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 64 Issue 11 Pages: e1901218 Pub: 2020 Jun Epub: 2020 May 25 Authors Liu J , Wang Y , Wang Z , Hao Y , Bai W , Wang Z , Wang J , |
|
|
Cereal byproducts have prebiotic potential in mice fed a high-fat diet. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 62 Issue 32 Pages: 8169-78 Pub: 2014 Aug 13 Epub: 2014 Jul 29 Authors Berger K , Falck P , Linninge C , Nilsson U , Axling U , Grey C , Stålbrand H , Nordberg Karlsson E , Nyman M , Holm C , Adlercreutz P , |
|
|
Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation. ✅
Go to Publication ✅
BMC nutrition (BMC Nutr ) Vol: 5 Issue Pages: 12 Pub: 2019 Epub: 2019 Mar 6 Authors Laatikainen R , Jalanka J , Loponen J , Hongisto SM , Hillilä M , Koskenpato J , Korpela R , Salonen A , |
|
|
Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation. ✅
Go to Publication ✅
BMC nutrition (BMC Nutr ) Vol: 5 Issue Pages: 12 Pub: 2019 Epub: 2019 Mar 6 Authors Laatikainen R , Jalanka J , Loponen J , Hongisto SM , Hillilä M , Koskenpato J , Korpela R , Salonen A , |
|
|
Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation. ✅
Go to Publication ✅
BMC nutrition (BMC Nutr ) Vol: 5 Issue Pages: 12 Pub: 2019 Epub: 2019 Mar 6 Authors Laatikainen R , Jalanka J , Loponen J , Hongisto SM , Hillilä M , Koskenpato J , Korpela R , Salonen A , |
|
|
Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation. ✅
Go to Publication ✅
BMC nutrition (BMC Nutr ) Vol: 5 Issue Pages: 12 Pub: 2019 Epub: 2019 Mar 6 Authors Laatikainen R , Jalanka J , Loponen J , Hongisto SM , Hillilä M , Koskenpato J , Korpela R , Salonen A , |
|
|
Effects of whole-grain cereals on fecal microbiota and short-chain fatty acids in dogs: a comparison of rye, oats and wheat. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 13 Issue 1 Pages: 10920 Pub: 2023 Jul 5 Epub: 2023 Jul 5 Authors Palmqvist H , Höglund K , Ringmark S , Lundh T , Dicksved J , |
|
|
Effects of whole-grain cereals on fecal microbiota and short-chain fatty acids in dogs: a comparison of rye, oats and wheat. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 13 Issue 1 Pages: 10920 Pub: 2023 Jul 5 Epub: 2023 Jul 5 Authors Palmqvist H , Höglund K , Ringmark S , Lundh T , Dicksved J , |
|
|
Fecal microbiota composition affects in vitro fermentation of rye, oat, and wheat bread. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 13 Issue 1 Pages: 99 Pub: 2023 Jan 3 Epub: 2023 Jan 3 Authors Pirkola L , Dicksved J , Loponen J , Marklinder I , Andersson R , |
|
|
Effects of whole-grain wheat, rye, and lignan supplementation on cardiometabolic risk factors in men with metabolic syndrome: a randomized crossover trial. ✅
Go to Publication ✅
The American journal of clinical nutrition (Am J Clin Nutr ) Vol: 111 Issue 4 Pages: 864-876 Pub: 2020 Apr 1 Epub: Authors Eriksen AK , Brunius C , Mazidi M , Hellström PM , Risérus U , Iversen KN , Fristedt R , Sun L , Huang Y , Nørskov NP , Knudsen KEB , Kyrø C , Olsen A , Tjønneland A , Dicksved J , Landberg R , |
|
|
The effects of fermented rye products on gut microbiota and their association with metabolic factors in Chinese adults - an explorative study. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 19 Pages: 9141-9150 Pub: 2021 Oct 4 Epub: 2021 Oct 4 Authors Liu Y , Xue K , Iversen KN , Qu Z , Dong C , Jin T , Hallmans G , Åman P , Johansson A , He G , Landberg R , |
|
|
Prebiotic potential of wheat and dark rye: modulation of gut microbiota and short-chain fatty acid-producing bacteria. ✅
Go to Publication ✅
Food science and biotechnology (Food Sci Biotechnol ) Vol: 34 Issue 11 Pages: 2563-2570 Pub: 2025 Jul Epub: 2025 Apr 29 Authors Kim J , Kim J , Kim G , Kim S , Shin H , |
|
|
Prebiotic potential of wheat and dark rye: modulation of gut microbiota and short-chain fatty acid-producing bacteria. ✅
Go to Publication ✅
Food science and biotechnology (Food Sci Biotechnol ) Vol: 34 Issue 11 Pages: 2563-2570 Pub: 2025 Jul Epub: 2025 Apr 29 Authors Kim J , Kim J , Kim G , Kim S , Shin H , |
|
|
Prebiotic potential of wheat and dark rye: modulation of gut microbiota and short-chain fatty acid-producing bacteria. ✅
Go to Publication ✅
Food science and biotechnology (Food Sci Biotechnol ) Vol: 34 Issue 11 Pages: 2563-2570 Pub: 2025 Jul Epub: 2025 Apr 29 Authors Kim J , Kim J , Kim G , Kim S , Shin H , |
|
|
Metabolite Biomarkers Linking a High-Fiber Rye Intervention with Cardiometabolic Risk Factors: The RyeWeight Study. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: Issue Pages: Pub: 2025 Aug 21 Epub: 2025 Aug 21 Authors Unión Caballero A , Meroño T , Åberg S , Nordin E , Dicksved J , Sánchez-Pla A , Cubedo M , Carmona-Pontaque F , Iversen KN , Martínez-Huélamo M , Guadall A , Landberg R , Andrés-Lacueva C , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
